We can’t show the full text here under this license. Use the link below to read it at the source.
N 6 ‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis
How m6A-modified RNA controls tiny particle release to create an immune-suppressing environment before stomach cancer spreads to the abdomen
AI simplified
Abstract
Overexpression of METTL3 in gastric cancer cells is associated with enhanced RAB27A translation and increased exosome biogenesis.
- METTL3 modifies the mRNA of RAB27A, facilitating its translation and promoting exosome production.
- Exosomes derived from METTL3-overexpressed cells contain the miRNA-17-92 cluster, which targets SRCIN1 to activate SRC signaling in peritoneal macrophages.
- Activated macrophages produce a shift in cytokine profiles, elevating IL-10 and TNF while reducing IL-1 and IL-6.
- This cytokine shift is linked to inhibited T cell proliferation and cytotoxic activities, contributing to an immunosuppressive environment.
- The relationship between METTL3, macrophage activation, and peritoneal metastasis is supported by clinical sample analysis.
AI simplified
Key numbers
5.146
Increased Risk of Peritoneal Metastasis
Odds ratio comparing METTL3-high to METTL3-low gastric cancer patients.
2.4×
Cytokine Elevation
Fold increase in IL-10 levels compared to control exosomes.